50

Hygeia Healthcare Holdings Co LtdFRA Hygeia Healthcare Stock Report

Last reporting period 30 Jun, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

1.409

Small

Exchange

XFRA - Deutsche Boerse AG

50I.F Stock Analysis

50

Uncovered

Hygeia Healthcare Holdings Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

61/100

Moderate score

Market cap $B

1.409

Dividend yield

0.38 %

Shares outstanding

631.52 B

Hygeia Healthcare Holdings Co., Ltd. operates as a biopharmaceutical company that focuses on the development of new clinical drugs. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-06-29. Through its subsidiaries, the Company mainly operates three segments. The Hospital Business segment provides outpatient and inpatient services for patients through its own hospitals. The Radiotherapy Business segment provides radiotherapy center consulting services, as well as the leasing, sales, disposal, and post-sales repair and maintenance services of radiotherapy equipment. The Hospital Management Service segment provides management related services to other hospitals. The firm conducts its businesses in the domestic market.

View Section: Eyestock Rating